Daniel Magoon
- Hematology top 1%
- Acute Myeloid Leukemia Research 17
- Hematopoietic Stem Cell Transplantation 6
- Chronic Myeloid Leukemia Treatments 3
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 2
- Renal and related cancers 2
- Oncology top 10%
- Chemokine receptors and signaling 6
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
-
- Acute Lymphoblastic Leukemia research 9
- Co-authors
- Patrick A. BrownEdward Allan R. SisonPeter ValentAgustin ChicasScott W. LoweJunwei ShiChristopher JohnsHarald Herrmann
- Cited by
- HematologyMolecular BiologyOncology
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Daniel Magoon
21 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Hematology 893
- Molecular Biology 1.5k
- Oncology 353
- Genetics 119
- Immunology 185
Countries citing papers authored by Daniel Magoon
This map shows the geographic impact of Daniel Magoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Magoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Magoon more than expected).
Fields of papers citing papers by Daniel Magoon
This network shows the impact of papers produced by Daniel Magoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Magoon. The network helps show where Daniel Magoon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Magoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 2 | |
| 2 | 2018 | 7 | |
| 3 | 2017 | 62 | |
| 4 | 2017 | 0 | |
| 5 | 2016 | 56 | |
| 6 | 2015 | 29 | |
| 7 | 2015 | 89 | |
| 8 | 2014 | 49 | |
| 9 | 2014 | 1 | |
| 10 | 2013 | 27 | |
| 11 | 2013 | 4 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 6 | |
| 14 | 2012 | 1 | |
| 15 | 2012 | 6 | |
| 16 | 2012 | 3 | |
| 17 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiabreakdown → | 2011 | 1438 |
| 18 | 2011 | 1 | |
| 19 | 2010 | 1 | |
| 20 | 2010 | 1 |
About Daniel Magoon
Daniel Magoon is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Immunology, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (9 papers), Hematopoietic Stem Cell Transplantation (6 papers), Chemokine receptors and signaling (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Hematology (893 citations), Molecular Biology (1.5k citations), Oncology (353 citations), Genetics (119 citations) and Immunology (185 citations). Daniel Magoon has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Patrick A. Brown, Edward Allan R. Sison, Peter Valent, Agustin Chicas, Scott W. Lowe, Junwei Shi, Christopher Johns, Harald Herrmann, Mark Wunderlich and Meredith J. Taylor. Their work appears in journals such as Blood, Oncotarget, Pediatric Blood & Cancer, Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.